Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141


Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model.

Kosinska AD, Zhang E, Johrden L, Liu J, Seiz PL, Zhang X, Ma Z, Kemper T, Fiedler M, Glebe D, Wildner O, Dittmer U, Lu M, Roggendorf M.

PLoS Pathog. 2013;9(6):e1003391. doi: 10.1371/journal.ppat.1003391. Epub 2013 Jun 13.


DNA prime-adenovirus boost immunization induces a vigorous and multifunctional T-cell response against hepadnaviral proteins in the mouse and woodchuck model.

Kosinska AD, Johrden L, Zhang E, Fiedler M, Mayer A, Wildner O, Lu M, Roggendorf M.

J Virol. 2012 Sep;86(17):9297-310. doi: 10.1128/JVI.00506-12. Epub 2012 Jun 20.


Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

Lu M, Hilken G, Kruppenbacher J, Kemper T, Schirmbeck R, Reimann J, Roggendorf M.

J Virol. 1999 Jan;73(1):281-9.


Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection.

Liu J, Zhang E, Ma Z, Wu W, Kosinska A, Zhang X, Möller I, Seiz P, Glebe D, Wang B, Yang D, Lu M, Roggendorf M.

PLoS Pathog. 2014 Jan;10(1):e1003856. doi: 10.1371/journal.ppat.1003856. Epub 2014 Jan 2.


Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.

Lu M, Klaes R, Menne S, Gerlich W, Stahl B, Dienes HP, Drebber U, Roggendorf M.

J Hepatol. 2003 Sep;39(3):405-13.


Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.

Frank I, Budde C, Fiedler M, Dahmen U, Viazov S, Lu M, Dittmer U, Roggendorf M.

J Virol. 2007 Jul;81(13):7156-63. Epub 2007 Apr 25.


The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.

Roggendorf M, Yang D, Lu M.

Pathol Biol (Paris). 2010 Aug;58(4):308-14. doi: 10.1016/j.patbio.2010.04.005. Epub 2010 Jun 19. Review.


Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.

Fiedler M, Kosinska A, Schumann A, Brovko O, Walker A, Lu M, Johrden L, Mayer A, Wildner O, Roggendorf M.

J Virol. 2013 Jul;87(13):7708-16. doi: 10.1128/JVI.00645-13. Epub 2013 May 1.


Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.

Korba BE, Cote PJ, Menne S, Toshkov I, Baldwin BH, Wells FV, Tennant BC, Gerin JL.

Antivir Ther. 2004 Dec;9(6):937-52.


Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.

Roggendorf M, Schulte I, Xu Y, Lu M.

J Viral Hepat. 2007 Nov;14 Suppl 1:51-7. Review.


Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.

Reynolds TD, Buonocore L, Rose NF, Rose JK, Robek MD.

J Virol. 2015 Oct;89(20):10407-15. doi: 10.1128/JVI.01184-15. Epub 2015 Aug 5.


Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model.

Lu M, Menne S, Yang D, Xu Y, Roggendorf M.

Expert Opin Investig Drugs. 2007 Jun;16(6):787-801. Review.


Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome-DNA complexes as adjuvant.

Cote PJ, Butler SD, George AL, Fairman J, Gerin JL, Tennant BC, Menne S.

J Med Virol. 2009 Oct;81(10):1760-72. doi: 10.1002/jmv.21566.


Supplemental Content

Support Center